STSiva Vijayakumar Tharumasivam

Siva Vijayakumar Tharumasivam

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Siva Vijayakumar Tharumasivam has a total of 9 co-authors. Here are the top co-authors by number of shared publications:

  • Ashajyothi Chavaan

    Department of Studies in Biotechnology, Vijayanagar Sri Krishnadevarya University, Ballari, India

    1 shared publication
  • Chandran Janani

    Department of Biotechnology, Srimad Andavan Arts and Science College (Autonomous), Affiliated to Bharathidasan University, Tiruchirappalli, India

    1 shared publication
  • Hamad M Alkahtani

    Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia

    1 shared publication
  • Irfan Aamer Ansari

    Department of Drug Science and Technology, University of Turin, Turin, Italy

    1 shared publication
  • Rahul Francis

    Department of Biotechnology, Srimad Andavan Arts and Science College (Autonomous), Affiliated to Bharathidasan University, Tiruchirappalli, India

    1 shared publication
  • Ramanathan Kalyanaraman

    Department of Biotechnology, Srimad Andavan Arts and Science College (Autonomous), Affiliated to Bharathidasan University, Tiruchirappalli, India

    1 shared publication

Latest Publications

  • Open Access

    Piperine’s potential in treating polycystic ovarian syndrome explored through in-silico docking

    by Rahul Francis, Ramanathan Kalyanaraman, Vasuki Boominathan, Sudharsan Parthasarathy, Ashajyothi Chavaan, Irfan Aamer Ansari, Siddique Akber Ansari, Hamad M Alkahtani, Janani Chandran, Siva Vijayakumar Tharumasivam

    Polycystic Ovarian Syndrome (PCOS) is a multifaceted metabolic and hormonal condition that impacts women in their procreative ages, identified by ovarian dysfunction, hyperandrogenaemia overweight and insulin insensitivity. The piperine, an important alkaloid compound of black pepper has shown promise in modulating various physiological processes. In this work, employed computational docking studies to explore the potential of piperine as a treatment for PCOS. Utilizing computational methods, we analyzed the binding interactions between piperine and key molecular targets implicated in PCOS pathogenesis, including hyperandrogenism, and “oligomenorrhea. The network pharmacology analysis report found 988 PCOS-related genes, 108 hyperandrogenism-related genes, and 377 oligomenorrhea-related genes, and we finally shortlisted 5 common genes in PCOS, hyperandrogenism, and “oligomenorrhea”: NR3C1, PPARG, FOS, CYP17A1, and H6PD. Our results reveal favorable binding affinities with PPARG (-8.34 Kcal/mol) and H6PD (-8.70 Kcal/mol) and interaction patterns, suggesting the potential of piperine to modulate these targets. Moreover, the reliability of the piperine-target interactions was revealed by molecular simulations studies. These findings support further experimental investigations to validate the therapeutic efficacy of piperine in PCOS management. The integration of computational approaches with experimental studies has the potential to lay the groundwork for the creation of new therapies specifically targeting PCOS and related endocrine disorders.